The ERA Congress provided an excellent platform to discuss the latest innovations and research findings in the fields of nephrology and dialysis treatment. New methods for diagnosing and treating kidney diseases were extensively debated during the congress. The innovations in chronic kidney disease and dialysis treatment, in particular, garnered significant interest from the participants.
Throughout the congress, we had the opportunity to closely examine the products and services offered by competing firms. We gained insights into which companies are developing which technologies, which markets they are focusing on, and their customer feedback. These analyses will aid us in developing strategies to enhance our competitive edge in the market.
The ERA Congress offered numerous opportunities to meet and network with other professionals in the field. By exchanging information with experts from different countries, we laid the groundwork for new collaborations and partnerships. Additionally, through interactive events and presentations conducted during the congress, we had the chance to communicate our company’s vision and mission to a broad audience.
Dialysis Patient Numbers by Country
The congress also included discussions on the distribution of dialysis patients by country and current reports addressing the needs of these patients. This data is crucial for determining the services and strategies we will offer in different markets. The increase in the number of patients, especially in the European and Asian markets, will enable us to develop new projects targeted at these regions.
At the ERA Congress, the latest advancements in dialysis water treatment technologies were also addressed. As healthcare professionals and technology providers, we aim to enhance the effectiveness and reliability of our products by closely following innovations in this field. The new devices we introduced at the congress are designed to elevate hygiene and safety standards in dialysis treatment.
Introduction of the RIVAMED TP S-XL Series
We had the opportunity to showcase our new RIVAMED TP S-XL series at the congress. These devices use dual-stage reverse osmosis technology to ensure high-quality water in hemodialysis treatment. Here are the key features of the RIVAMED TP S-XL series:
- Dual-Stage Configuration: The RIVAMED TP ensures optimal permeate quality even with low-quality feed water.
- High Security: The independent dual-stage structure ensures continuous treatment by taking over responsibility if one stage fails.
- User-Friendly Interface: A multi-color touchscreen interface that simplifies system configuration and monitoring.
- Chemical and Thermal Disinfection: Semi-automatic chemical disinfection and fully automatic thermal disinfection programs.
- High Hygiene Standards: Design with no dead legs ensures maximum hygiene.
Additionally, the congress included comprehensive information sharing about integrating and regulating more efficient systems by reducing energy and water losses. At RIVAMED, we aim to enhance the effectiveness and reliability of our products by closely following innovations in this field.
The 61st ERA Congress was a significant step for RIVAMED to strengthen our position within the industry and create new opportunities. The network we established with both competing firms and potential business partners will illuminate our future projects. In the coming period, we will continue to enhance the quality of life for our patients and maintain our leadership in the industry with the innovations we offer in dialysis treatment and water purification technologies.
We would like to extend our gratitude to all the participants who visited our booth and shared their experiences with us at this important event. With the knowledge we gained and the new connections we established following the ERA Congress, we will continue to increase our contributions to the healthcare sector.
